In a more clinically relevant CLP-induced sepsis, the delayed administration of HMGB1-specific neutralizing antibodies beginning 24 h after CLP dose-dependently rescued rodents from lethal sepsis [32, 66, 69]. The gene discussed is HMGB1; the disease is Sepsis.